REST EZ Inc.
RTEZ · Pharmaceutical Preparations · 27.5M shares · +0%/yr ↓ buyback · EDGAR filings ↗
Grade
F20Dormant/near-insolvent micro-cap — deep losses (ROA -2633%) and a collapse in revenue (-100%).
Strengths
- n/a — no durable positives
Risks
- Near-insolvent/negligible operations — per metrics
- Going-concern fragility — per 10-K
- Shell-like financials — per 10-K
Notable findings
- Revenue declineRevenue -100.0% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-2633.3%
Return on assets
-2633.3%
Revenue growth (QoQ)
-100.0%
Tangible book value
$300
Cash & investments
$300
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-02-10 | 2025-12-31 | 0001185185-26-000463 ↗ |
| 10-Q | 2025-12-23 | 2025-06-30 | 0001185185-25-002151 ↗ |
| 10-Q | 2025-12-23 | 2025-09-30 | 0001185185-25-002153 ↗ |
| 10-K | 2025-12-16 | 2025-03-31 | 0001185185-25-002060 ↗ |
| 8-K | 2025-07-10 | 2025-07-02 | 0001185185-25-000750 ↗ |
| 8-K | 2025-07-09 | 2025-07-08 | 0001733861-25-000005 ↗ |
| 10-Q | 2025-04-25 | 2024-12-31 | 0001185185-25-000352 ↗ |
| 10-Q | 2025-04-25 | 2024-06-30 | 0001185185-25-000347 ↗ |
| 10-Q | 2025-04-25 | 2024-09-30 | 0001185185-25-000349 ↗ |
| 10-K | 2025-02-13 | 2024-03-31 | 0001185185-25-000130 ↗ |
| 10-Q | 2024-03-07 | 2023-12-31 | 0001185185-24-000204 ↗ |
| 10-Q | 2024-01-16 | 2023-09-30 | 0001185185-24-000080 ↗ |